UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 432

Sortiert nach

Non-immunotherapy options for the first-line management of hepatocellular carcinoma: exploring the evolving role of sorafenib and lenvatinib in advanced disease

Current oncology (Toronto), 2020-11, Vol.27 (Suppl 3), p.S165-172

2020

Link zum Volltext

Verfügbarkeit prüfen

Collaborations in Dietetics Education across Countries

Journal of the Academy of Nutrition and Dietetics, 2016-09, Vol.116 (9), p.A68-A68

2016

Link zum Volltext

Verfügbarkeit prüfen

Resistance to epidermal growth factor receptor tyrosine kinase inhibitors, T790M, and clinical trials

Current oncology (Toronto), 2018-06, Vol.25 (Suppl 1), p.S28-37

2018

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal health utilities, symptoms and toxicities in patients with ALK- rearranged lung cancer treated with tyrosine kinase inhibitors: a prospective real-world assessment

Current oncology (Toronto), 2020-12, Vol.27 (6), p.e552-559

2020

Link zum Volltext

Verfügbarkeit prüfen

A Risk Score Model for Locoregional Recurrence Following Upfront Surgery for Pancreatic Adenocarcinoma: Implications for Adjuvant Therapy

Clinical oncology (Royal College of Radiologists (Great Britain)), 2021-08, Vol.33 (8), p.527-535

2021

Link zum Volltext

Verfügbarkeit prüfen

Molecular profiling of PDAC and response to chemotherapy: An update from the COMPASS trial

Annals of oncology, 2018-10, Vol.29, p.viii240-viii241

2018

Link zum Volltext

Verfügbarkeit prüfen

2511 TI-CE for relapsed germ cell tumours: A European BMT centre experience

European journal of cancer (1990), 2015-09, Vol.51, p.S477-S478

2015

Link zum Volltext

Verfügbarkeit prüfen

Is chemotherapy always required for cancer in pregnancy? An observational study

Irish journal of medical science, 2017-11, Vol.186 (4), p.875-881

2017

Link zum Volltext

Verfügbarkeit prüfen

A single-centre analysis of 30 patients with relapsed germ cell tumours treated with the TI-CE regimen

Bone marrow transplantation (Basingstoke), 2016-06, Vol.51 (6), p.856-859

2016

Link zum Volltext

Verfügbarkeit prüfen

Perioperative chemotherapy in the treatment of osteosarcoma: a 26-year single institution review

Clinical sarcoma research, 2015-07, Vol.5 (1), p.17-17, Article 17

2015

Link zum Volltext

Verfügbarkeit prüfen

Trial in Progress: Atezolizumab and Bevacizumab Pre-liver Transplantation for Patients with Hepatocellular Carcinoma beyond Milan Criteria

HPB (Oxford, England), 2023, Vol.25, p.S560-S561

2023

Link zum Volltext

Verfügbarkeit prüfen

Non-Immunotherapy Options for the First-Line Management of Hepatocellular Carcinoma: Exploring the Evolving Role of Sorafenib and Lenvatinib in Advanced Disease

Current oncology (Toronto), 2020-11, Vol.27 (13), p.165

2020

Link zum Volltext

Verfügbarkeit prüfen

P35.03 Methylation Signatures Associated with T790M Status in Progressive NSCLC

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S420-S420

2021

Link zum Volltext

Verfügbarkeit prüfen

Riverina men's study: a preliminary exploration of the diet, alcohol use and physical activity behaviours and attitudes of rural men in two Australian New South Wales electorates

Rural and remote health, 2008-01, Vol.8 (1), p.851-851

2008

Link zum Volltext

Verfügbarkeit prüfen

P1.13-15 Detection of EGFR Mutations in cfDNA and Development of Resistance

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S587-S587

2018

Link zum Volltext

Verfügbarkeit prüfen

Cascade testing following universal immunohistochemistry for mismatch repair protiens

Annals of oncology, 2016-10, Vol.27, p.vi186-vi186

2016

Link zum Volltext

Verfügbarkeit prüfen

PD-0423: Risk group classification for locoregional failure following upfront surgery for pancreatic cancer

Radiotherapy and oncology, 2020-11, Vol.152, p.S230-S231

2020

Link zum Volltext

Verfügbarkeit prüfen

81P The influence of comorbidity on health utility score (HUS) and health-related quality of life (HRQoL) in small cell lung cancer (SCLC) compared to non-small cell lung cancer (NSCLC)

Journal of thoracic oncology, 2018-04, Vol.13 (4), p.S44-S45

2018

Link zum Volltext

Verfügbarkeit prüfen

P2.15-10 Determinants of Health Utility Scores (HUS) in Patients with ALK Rearranged Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S820-S821

2018

Link zum Volltext

Verfügbarkeit prüfen

P86.08 Phase 2 Study of Zenocutuzumab (MCLA-128), a Bispecific HER2/HER3 Antibody in NRG1 Fusion-Positive Advanced Solid Tumors

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S675-S675

2021

Link zum Volltext

Verfügbarkeit prüfen

Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients

Pediatrics (Evanston), 2009-05, Vol.123 (5), p.1360

2009

Link zum Volltext

Verfügbarkeit prüfen

MA18.09 Predictors of Health Utility Scores (HUS) in Advanced EGFR-Mutated NSCLC

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S420-S421

2018

Link zum Volltext

Verfügbarkeit prüfen

P1.13-11 PRO-CTCAE Toxicities in Advanced NSCLC Patients with EGFR Mutations: A Real World Assessment

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S586-S586

2018

Link zum Volltext

Verfügbarkeit prüfen

P1.01-42 Real-World Evaluation of Tolerability in Older Adult Patients (≥75 years old) with EGFR-mutated NSCLC

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S476-S477

2018

Link zum Volltext

Verfügbarkeit prüfen

Osteosarcoma in a Patient Receiving Long-Term TNF Inhibitor Therapy

Irish medical journal, 2016-03, Vol.109 (3), p.375-375

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 432

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieMaterials Research Bulletin

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(368)
Mit Volltextzugriff
(345)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(235)
Life Sciences & Biomedicine
(169)
Humans
(124)
Biological And Medical Sciences
(76)
Medical Sciences
(52)
Male
(51)
Physical Sciences
(50)
Animals
(48)
Female
(41)
Technology
(33)
Fundamental And Applied Biological Sciences. Psychology
(31)
Adult
(30)
General & Internal Medicine
(29)
Middle Aged
(24)
Cardiac & Cardiovascular Systems
(21)
Cardiovascular System & Cardiology
(21)
Physics
(21)
Materials Science
(20)
Chemistry
(19)
Medicine, General & Internal
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Non-immunotherapy options for the first-line management of hepatocellular carcinoma: exploring the evolving role of sorafenib and lenvatinib in advanced disease

Collaborations in Dietetics Education across Countries

Resistance to epidermal growth factor receptor tyrosine kinase inhibitors, T790M, and clinical trials

Longitudinal health utilities, symptoms and toxicities in patients with ALK- rearranged lung cancer treated with tyrosine kinase inhibitors: a prospective real-world assessment

A Risk Score Model for Locoregional Recurrence Following Upfront Surgery for Pancreatic Adenocarcinoma: Implications for Adjuvant Therapy

Molecular profiling of PDAC and response to chemotherapy: An update from the COMPASS trial

2511 TI-CE for relapsed germ cell tumours: A European BMT centre experience

Is chemotherapy always required for cancer in pregnancy? An observational study

A single-centre analysis of 30 patients with relapsed germ cell tumours treated with the TI-CE regimen

Perioperative chemotherapy in the treatment of osteosarcoma: a 26-year single institution review

Trial in Progress: Atezolizumab and Bevacizumab Pre-liver Transplantation for Patients with Hepatocellular Carcinoma beyond Milan Criteria

Non-Immunotherapy Options for the First-Line Management of Hepatocellular Carcinoma: Exploring the Evolving Role of Sorafenib and Lenvatinib in Advanced Disease

P35.03 Methylation Signatures Associated with T790M Status in Progressive NSCLC

Riverina men's study: a preliminary exploration of the diet, alcohol use and physical activity behaviours and attitudes of rural men in two Australian New South Wales electorates

P1.13-15 Detection of EGFR Mutations in cfDNA and Development of Resistance

Cascade testing following universal immunohistochemistry for mismatch repair protiens

PD-0423: Risk group classification for locoregional failure following upfront surgery for pancreatic cancer

81P The influence of comorbidity on health utility score (HUS) and health-related quality of life (HRQoL) in small cell lung cancer (SCLC) compared to non-small cell lung cancer (NSCLC)

P2.15-10 Determinants of Health Utility Scores (HUS) in Patients with ALK Rearranged Non-Small Cell Lung Cancer

P86.08 Phase 2 Study of Zenocutuzumab (MCLA-128), a Bispecific HER2/HER3 Antibody in NRG1 Fusion-Positive Advanced Solid Tumors

Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients

MA18.09 Predictors of Health Utility Scores (HUS) in Advanced EGFR-Mutated NSCLC

P1.13-11 PRO-CTCAE Toxicities in Advanced NSCLC Patients with EGFR Mutations: A Real World Assessment

P1.01-42 Real-World Evaluation of Tolerability in Older Adult Patients (≥75 years old) with EGFR-mutated NSCLC

Osteosarcoma in a Patient Receiving Long-Term TNF Inhibitor Therapy

Aktive Filter

Suchergebnisse filtern